Liver Histology, Physiology and Pathology

Liver Histology, Physiology and Pathology - OMPATH

## 1. LIVER HISTOLOGY & PHYSIOLOGY ### Structural Units - **Lobule**: Hexagonal structure with a central vein in the middle and portal triads at the periphery. - **Acinus**: Functional unit based on microcirculation. - **Portal Triad**: Contains a bile duct, hepatic artery branch, and portal vein branch. - **Central Vein**: Tributary of the hepatic vein. ### Acinar Zones | Zone | Location | Oxygenation | Affected by | |---|---|---|---| | Zone 1 | Periportal | Best | Phosphorus poisoning, eclampsia | | Zone 2 | Midzonal | Intermediate | Yellow fever | | Zone 3 | Centrilobular | Worst | Alcohol, CCl4, ischemia, shock, right heart failure | ### Liver Functions - Bilirubin metabolism and excretion. - Bile acid synthesis (12-36g/day): Cholic acid and chenodeoxycholic acid. - Secreted as taurine and glycine conjugates. - 10-20% deconjugated in ileum (enterohepatic circulation). - **Functions of bile**: 1. Elimination of water-insoluble bilirubin, excess cholesterol, and xenobiotics. 2. Emulsification of dietary fat in the gut. ## 2. BILIRUBIN METABOLISM ### Pathway - Aging RBCs → Heme → (Heme oxygenase) → Biliverdin → (Biliverdin reductase) → Bilirubin. - Bilirubin binds to albumin → liver → conjugated with glucuronic acid (UDP-glucuronosyltransferase). - Bilirubin glucuronides → excreted in bile → gut → urobilinogen → stercobilin (stool). - Some urobilinogen is reabsorbed via enterohepatic circulation and excreted in urine. ### Jaundice - Bilirubin > 2 mg/dl results in jaundice (icterus). - **Kernicterus**: Unconjugated bilirubin accumulation in the brain; highly toxic. ### Causes of Jaundice 1. Excessive production (hemolysis). 2. Reduced hepatocellular uptake. 3. Impaired conjugation (Gilbert's, Crigler-Najjar syndromes). 4. Decreased hepatocellular excretion. 5. Impaired bile flow (cholestasis). ### Types of Bilirubin | Feature | Unconjugated | Conjugated | |---|---|---| | Water solubility | Insoluble | Soluble | | Albumin binding | Tight | Loose | | Urine | Absent | Present (tea-colored) | | Toxicity | Toxic (kernicterus) | Nontoxic | | Lab | Total minus direct | Direct bilirubin | | Cause | Hemolysis, impaired conjugation | Cholestasis, hepatocellular disease | ## 3. LIVER FUNCTION TESTS (LFTs) | Category | Tests | |---|---| | Hepatocyte integrity | AST (SGOT), ALT (SGPT), LDH | | Biliary excretory function | Serum bilirubin, Alkaline phosphatase (ALP), GGT | | Hepatocyte synthetic function | Albumin, Prothrombin time (PT), Ammonia | ### Key Clinical Correlations - **ALT** is more specific for liver injury than AST. - **AST:ALT > 2:1** suggests alcoholic liver disease. - Isolated elevation of **Alkaline phosphatase** suggests cholestasis or biliary obstruction. - Low Albumin + prolonged PT indicates severe hepatocellular dysfunction. ## 4. HISTOLOGIC PATTERNS OF HEPATIC INJURY | Pattern | Description | Associated with | |---|---|---| | Steatosis | Fat (TG) in hepatocytes | Alcohol, NAFLD, obesity, drugs | | Ballooning degeneration | Hydropic swelling | Alcoholic/viral hepatitis | | Councilman bodies | Acidophilic apoptotic hepatocytes | Acute viral hepatitis | | Mallory bodies | Eosinophilic cytokeratin inclusions | Alcoholic hepatitis, Wilson's, NASH | | Piecemeal necrosis | Periportal necrosis | Chronic hepatitis | | Bridging necrosis | Portal-portal or portal-central | Severe hepatitis | | Massive necrosis | Entire lobules | Fulminant hepatitis | | Fibrosis | Collagen deposition | Chronic liver disease | | Cirrhosis | Regenerative nodules + fibrosis | End-stage liver disease | ## 5. CHOLESTASIS ### Definition Systemic retention of bilirubin and other solutes (bile salts, cholesterol) due to hepatocellular dysfunction or biliary obstruction. ### Clinical Features - Jaundice and dark urine. - **Pruritis** (bile salt deposition in skin). - Skin xanthomas (cholesterol deposits). - Malabsorption of fat-soluble vitamins (A, D, E, K). - Pale/clay-colored stools. ### Laboratory Findings - Elevated conjugated bilirubin. - Significantly elevated Alkaline phosphatase (ALP) and GGT. ## 6. HEPATIC FAILURE ### Definition Loss of 80-90% of hepatic functional capacity. ### Causes 1. **Chronic liver disease**: Cirrhosis. 2. **Massive hepatic necrosis**: Viral hepatitis, drugs (Acetaminophen, Halothane, Rifampicin), or mushroom toxins (Amanita phalloides). 3. **Dysfunction without necrosis**: Reye's syndrome, acute fatty liver of pregnancy. ### Clinical Consequences - **Encephalopathy**: Due to hyperammonemia; characterized by **Asterixis** (flapping tremor). - **Portal Hypertension**: Ascites, splenomegaly, esophageal varices, and caput medusae. - **Synthetic Failure**: Hypoalbuminemia (edema), coagulopathy (bleeding), and hypoglycemia. - **Endocrine**: Gynecomastia and palmar erythema (impaired estrogen metabolism). - **Hepatorenal Syndrome**: Renal failure secondary to severe liver disease without intrinsic kidney pathology; characterized by low urinary sodium. ## 7. CIRRHOSIS ### Histo